• Reset
FDA Publishes Guidance for Payment to Study Participants
The FDA has issued a guidance document reinforcing the responsibility of the Institutional Review Board (IRB) as it…
ClinCard Answers Recruitment Challenges, Brings Security and Control to Phase I Research
All clinical research is difficult to recruit for, nearly 80% of clinical trials fail to meet clinical trial…
Why Payment Triggers Need More Than EDC
A common approach to automating the investigator payment process is by linking EDC or CTMS data with payment…
Sites Need Financial Visibility & Control for Optimal Performance
Strong, collaborative business partnerships are at the heart of all sustainable businesses. This is no different when it…
Private Equity, M&A, and Due Diligence Activities Drive Focus on Clean, Comprehensive Site Grant Payment Transactions
Six of the top 10 private equity healthcare deals in 2015 were in services, including outsourcing companies such…
Supporting Patient and Site Centricity in Orphan Drug Research
Orphan disease studies cost an average of 25 times more per patient than non-orphan trials.
Alzheimer’s Study Increases Patient Retention by 10%
How a leading sponsor increased patient retention and engagement with ClinCard
5 questions to build the case for site payment automation
It’s more than saving time, read what you should be thinking about when investing in a site payment…
What to think about when pitching patient reimbursement automation
Are you convinced you need to automate patient reimbursements, but you’re having a hard time “selling” this investment…
Top 5 Global Sponsor Automates Patient Reimbursements, Increases Retention by 10%
Read our case study about how ClinCard provided a measurable increase in patient retention with ClinCard